Caragh MurrayPlain Language Summary Program Manager at The Janssen Pharmaceutical Companies of Johnson & Johnson, USA
Agenda Sessions
Considerations for Presentation of Secondary Endpoints in Plain Language Clinical Trial Result Summaries: Multi-stakeholder Perspectives for Emerging Practice
, 8:40amView SessionPANEL: Considerations for Presentation of Secondary Endpoints in Plain Language Clinical Trial Result Summaries
, 10:20amView Session